Editorial: Closing sale of innovative treatment options for the treatment of diabetes and metabolic disorders?

about

Editorial: Closing sale of innovative treatment options for the treatment of diabetes and metabolic disorders?

Item

http://www.wikidata.org/entity/Q42416649

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Editorial: Closing sale of inn ...... betes and metabolic disorders?

@en

Editorial: Closing sale of inn ...... betes and metabolic disorders?

@nl

type

Item

label

Editorial: Closing sale of inn ...... betes and metabolic disorders?

@en

Editorial: Closing sale of inn ...... betes and metabolic disorders?

@nl

prefLabel

Editorial: Closing sale of inn ...... betes and metabolic disorders?

@en

Editorial: Closing sale of inn ...... betes and metabolic disorders?

@nl

P1476

Editorial: Closing sale of inn ...... betes and metabolic disorders?

@en

P2093

Christoph Schindler

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Statin-associated myopathy.

Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

Mechanisms of troglitazone hepatotoxicity.

P304

229-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1177/2042018811430839

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Schindler

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233405523

http://www.w3.org/2001/XMLSchema#string

P698

23148187

http://www.w3.org/2001/XMLSchema#string

P932

3474642

http://www.w3.org/2001/XMLSchema#string